Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT800 On-demand Treatment in Hemophilia A
CTR20160410Phase 3Completed
- Sponsor
- Shenzhou Cell Engineering Co., Ltd.
- Start
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of omfiloctocog alfa in hemophilia A, sponsored by Shenzhou Cell Engineering Co., Ltd.. Started Aug 2016; status: completed.
02
Drugs
omfiloctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20160410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160410.